Sweeping tax cuts and reduced spending on Medicaid and SNAP were signed into law by President Donald Trump. However, a key provision that would have paused new AI regulations was removed by the Senate.
The FDA's 2024 approval of the Farapulse system covered patients with paroxysmal atrial fibrillation. Now, however, the technology is officially approved for patients with more persistent symptoms.
The model spots previously undetected scarring patterns on cardiac MRI scans of patients with hypertrophic cardiomyopathy—a leading cause of sudden cardiac death among young people.
Sweeping tax cuts and reduced spending on Medicaid and SNAP were signed into law by President Donald Trump. However, a key provision that would have paused new AI regulations was removed by the Senate.